Form 4 for TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Accepted 2024-11-21 00:00:00 ET · period of report 2024-11-20 · accession 0000950170-24-129709 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-11-21 | 2024-11-20 | TEVA | Fox Christine | EVP, Head of U.S. Commercial | S - Sale+OE | $16.87 | -19.4K | 44.1K | -31% | -$327.1K |
| DT | 2024-11-21 | 2024-11-20 | TEVA | Fox Christine | EVP, Head of U.S. Commercial | M - OptEx | — | +63.5K | 63.5K | New | — |
| DT | 2024-11-21 | 2024-11-20 | TEVA | Fox Christine | EVP, Head of U.S. Commercial | M - OptEx | $0.00 | -63.5K | 190.5K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-11-20 | S | D | 19,388 | $16.87 | 44,104 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F4) Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II. |
| 2 | Common | Ordinary Shares | 2024-11-20 | M | A | 63,492 | — | 63,492 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. |
| 3 | Derivative | Restricted Share Units | 2024-11-20 | M | D | 63,492 | $0.00 | 190,476 | D | — · — to — | 63,492 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F5) Restricted share units were granted on November 20, 2023, with 63,492 vested on November 20, 2024, and 63,492 vesting on each of November 20, 2025, November 20, 2026 and November 20, 2027. |